Skip to main content

ICU MEDICAL INC/DE

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

ICUI$182.11+1.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets at and

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value data and treasury shares)

September 30,2025 · December 31,2024
(Unaudited)(1)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents$299,732$308,566
Accounts receivable, net of allowance for doubtful accounts $12,802 at September 30, 2025 and $12,977 at December 31, 2024191,541182,828
Inventories622,443584,676
Prepaid expenses and other current assets93,57481,531
Assets held for sale—284,382
TOTAL CURRENT ASSETS1,207,2901,441,983
PROPERTY, PLANT AND EQUIPMENT, net455,967442,746
OPERATING LEASE RIGHT-OF-USE ASSETS56,59853,295
GOODWILL1,498,7671,432,772
INTANGIBLE ASSETS, net664,827740,789
DEFERRED INCOME TAXES23,97624,211
OTHER ASSETS61,38565,097
INVESTMENTS IN UNCONSOLIDATED AFFILIATES134,0863,038
TOTAL ASSETS$4,102,896$4,203,931
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable$171,752$148,020
Accrued liabilities316,103306,923
Current portion of long-term debt—51,000
Income tax payable5,04517,328
Liabilities held for sale—32,911
TOTAL CURRENT LIABILITIES492,900556,182
LONG-TERM DEBT1,313,9311,531,858
OTHER LONG-TERM LIABILITIES93,55866,745
DEFERRED INCOME TAXES41,37148,814
INCOME TAX LIABILITY33,88635,097
COMMITMENTS AND CONTINGENCIES (Note 20)
STOCKHOLDERS’ EQUITY:
Convertible preferred stock, $1.00 par value; Authorized — 500 shares; Issued and outstanding — none——
Common stock, $0.10 par value; Authorized — 80,000 shares; Issued — 24,686 shares at September 30, 2025 and 24,518 shares at December 31, 2024; and outstanding — 24,686 shares at September 30, 2025 and 24,517 shares at December 31, 20242,4692,452
Additional paid-in capital1,451,1461,412,118
Treasury stock, at cost (99 shares at September 30, 2025 and 571 shares at December 31, 2024)(12)(92)
Retained earnings706,624690,158
Accumulated other comprehensive loss(32,977)(139,401)
TOTAL STOCKHOLDERS' EQUITY2,127,2501,965,235
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$4,102,896$4,203,931

(1)December 31, 2024 balances were derived from audited consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.